{"analyses":[{"ciLowerLimit":"-3.0","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"21","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","paramType":"Percent Difference","paramValue":"9.2"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"title":"Never"},{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"6"}],"title":"Sometimes"},{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"37"}],"title":"Usually/Always"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"43"}],"units":"Participants"}],"description":"-A discharge survey to document patient satisfaction and perceived pain control was given at the time of the last VAS score.","groups":[{"description":"Gabapentin liquid by mouth or per Tube 300mg twice a day","id":"OG000","title":"Gabapentin"},{"description":"Placebo liquid by mouth or Per Tube twice a day","id":"OG001","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The participants who did not answer this question on the survey were not evaluable for this outcome measure.","reportingStatus":"POSTED","timeFrame":"Once on post-op day 2 or day of discharge, whichever comes first","title":"Patient Reported Post-treatment Pain Satisfaction as Measured by How Often the Participant's Pain Was Well Controlled","type":"SECONDARY","unitOfMeasure":"Participants"}